Glen Santangelo
Stock Analyst at Jefferies
(2.36)
# 2,492
Out of 4,876 analysts
76
Total ratings
45.65%
Success rate
0.01%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $8.05 | -0.62% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $65.90 | +21.40% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $9.12 | +42.54% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $39.27 | +29.87% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $4.74 | +26.58% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $19.65 | +11.96% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $16.00 | +25.00% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.60 | -23.73% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.46 | +11.84% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $46.28 | -50.30% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $16.56 | +38.89% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $29.90 | +47.16% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $14.30 | +18.88% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $155.79 | +47.63% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.58 | +1,616.74% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $23.18 | +201.98% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $7.30 | +653.42% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $9.55 | +67.54% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.98 | +251.76% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $60.41 | -23.85% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $104.86 | -23.71% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.75 | +647.66% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $27.95 | +150.45% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.56 | +1,487.30% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.75 | -27.27% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.93 | +853.35% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.79 | +849.87% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $68.14 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $722.00 | -76.59% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $165.61 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $73.19 | +12.04% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $187.74 | +33.16% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.38 | +585.41% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $8.05
Upside: -0.62%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $65.90
Upside: +21.40%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.12
Upside: +42.54%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $39.27
Upside: +29.87%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $4.74
Upside: +26.58%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $19.65
Upside: +11.96%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $16.00
Upside: +25.00%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.60
Upside: -23.73%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.46
Upside: +11.84%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $46.28
Upside: -50.30%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.56
Upside: +38.89%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $29.90
Upside: +47.16%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $14.30
Upside: +18.88%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $155.79
Upside: +47.63%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.58
Upside: +1,616.74%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $23.18
Upside: +201.98%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $7.30
Upside: +653.42%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $9.55
Upside: +67.54%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.98
Upside: +251.76%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $60.41
Upside: -23.85%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $104.86
Upside: -23.71%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.75
Upside: +647.66%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $27.95
Upside: +150.45%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.56
Upside: +1,487.30%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.75
Upside: -27.27%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.93
Upside: +853.35%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.79
Upside: +849.87%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $68.14
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $722.00
Upside: -76.59%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $165.61
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $73.19
Upside: +12.04%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $187.74
Upside: +33.16%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.38
Upside: +585.41%